DSM boosts maternal and infant nutrition portfolio with new plant-based DHA oil

Headquarter of Royal DSM in Heerlen (The Netherlands)

Royal DSM, a purpose-led, global science-based company active in Nutrition, Health and Sustainable Living, launched its new, high-quality life’sDHA® SF55-O200DS oil for maternal and early life nutrition solutions. Offering a higher potency, this ingredient contains a minimum of 550 mg/g natural triglyceride DHA (docosahexaenoic acid), allowing manufacturers to achieve equivalent dosages of DHA in smaller product formats and meet the latest maternal nutrition trend for convenient capsule and tablet sizes.

Continue reading

An interview with Christophe Rupp-Dahlem: “Roquette is taking a holistic approach of bioeconomy”

Christophe Rupp-Dahlem

“Roquette is taking a holistic approach of bioeconomy by integrating various applications of plant-based resources and in particular those serving Nutrition and Health markets.” Christophe Rupp-Dahlem, Head of Global Public Affairs at Roquette, talks to Il Bioeconomista. In this exclusive interview he tells us what are Roquette’s main achievements in the bioeconomy and what the next steps.

Interview by Mario Bonaccorso

Continue reading

Cargill and DSM established the Joint Venture Avansya to reduce calories in their offerings

Cargill and Royal DSM, a global science-based company in Nutrition, Health and Sustainable Living, established a new joint venture, Avansya, to significantly reduce calories in their offerings to consumers. Together, the companies will produce highly sought-after, sweet-tasting molecules, such as steviol glycosides Reb M and Reb D through fermentation, giving food and beverage manufacturers an even more scalable, sustainable and low cost-in-use solution than if these same molecules were extracted from the stevia leaf.

Continue reading

Royal DSM to make an equity investment in Amyris

John Melo, President & Ceo of Amyris

Amyris, Inc., the U.S. industrial bioscience company, and Koninklijke DSM N.V. (Royal DSM), the Dutch global science-based company active in health, nutrition and materials, have agreed for DSM to make an equity investment in Amyris. At the same time, the companies will enter into a development cooperation focused on products for the global health and nutrition markets (including vitamins and other nutritional ingredients).
Continue reading